SCHEMBL24813334

SCHEMBL24813334

c1ccc2cc(-c3c4ccccc4c(-c4ccc5ccccc5c4)c4cc(-c5ccc(-c6nc(-c7ccc(-c8ccncc8)cc7)cc(-c7ccc(-c8ccncc8)cc7)n6)cc5)ccc34)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK9 P45984 4/20 0.43
MAPK10 P53779 4/20 0.43
MAPK8 P45983 3/20 0.43
CYP1A1 P04798 1/20 0.41
CYP1B1 Q16678 1/20 0.41
DHODH Q02127 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
CHEK1 O14757 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP17A1 P05093 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
CYP2C9 P11712 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PDGFRB P09619 1/20 0.39
PDGFRA P16234 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24812000 0.96 MAPK9 (0.43) MAPK9MAPK10MAPK8CYP1A1CYP1B1
SCHEMBL15977478 0.91 CYP1A1 (0.51) CYP1A1CYP1B1ALDH1A1MAPTHPGD
SCHEMBL24813342 0.91 MAPK9 (0.46) MAPK9MAPK10MAPK8CYP1A1CYP1B1
SCHEMBL15977605 0.91 CYP1A1 (0.51) CYP1A1CYP1B1ALDH1A1MAPTHPGD
SCHEMBL15077951 0.90 MAPK9 (0.50) MAPK9MAPK10MAPK8CYP1A1CYP1B1
SCHEMBL15977682 0.90 MAPK9 (0.50) MAPK9MAPK10MAPK8CYP1A1CYP1B1
SCHEMBL19271410 0.89 CYP1A1 (0.54) CYP1A1CYP1B1ALDH1A1MAPTHPGD
SCHEMBL15977515 0.89 CYP1A1 (0.49) CYP1A1CYP1B1ALDH1A1MAPTHPGD
SCHEMBL15077952 0.89 MAPK9 (0.51) MAPK9MAPK10MAPK8CHEK1CYP17A1
SCHEMBL24813351 0.89 NPC1 (0.48) MAPK9MAPK10MAPK8DHODHMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 MAPK9 1300/4885MAPK10 2313/4885MAPK8 2911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.